Albert Bourla
Albert Bourla is the CEO of Pfizer, a leading global pharmaceutical company. He gained significant recognition for his leadership during the COVID-19 pandemic, particularly for spearheading the rapid development of the vaccine. Recently, he has indicated Pfizer's focus on oral medications for obesity treatments, acknowledging the company's late entry into the injectable space.
Born on Oct 21, 1961 (63 years old)
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 5.00 | 0.03% | +0% | 67,886,011 | 18,264 | $2,700,000 | 726$ |
| Spain | 1 | 5.00 | 0.04% | +0% | 46,754,778 | 17,014 | $1,400,000 | 509$ |
| United States | 1 | 2.00 | 0.02% | +0% | 331,002,651 | 60,446 | $21,000,000 | 3,835$ |
| India | 1 | 4.00 | 0.02% | +0% | 1,380,004,385 | 243,344 | $2,900,000 | 511$ |
| Totals | 4 | 1,825,647,825 | 339,068 | $28,000,000 | 5,581$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Albert Bourla faced boos when introduced by Trump at a White House event.
2
India:
Albert Bourla, the chief executive of Pfizer, was in attendance at the event.
4
United Kingdom:
Albert Bourla is the CEO of Pfizer who exchanged calls and texts with Ursula von der Leyen regarding vaccine procurement.
5
Spain:
Albert Bourla, CEO of Pfizer, confirmed the company's focus on pills rather than injectables.
5